5,11-Dihydro-11-ethyl-5-methyl-2-trifluoromethanesulfonyloxy-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one → HCID 178462463, Verbindung
Reaktionsgleichung
[CH2:1]([N:3]1[C:9]2[N:10]=[CH:11][CH:12]=[CH:13][C:8]=2[C:7](=[O:14])[N:6]([CH3:15])[C:5]2[CH:16]=[CH:17][C:18](OS(C(F)(F)F)(=O)=O)=[N:19][C:4]1=2)[CH3:2].[CH3:28][C:29]1[C:33]([Sn](CCCC)(CCCC)CCCC)=[CH:32][NH:31][N:30]=1>>[CH2:1]([N:3]1[C:9]2[N:10]=[CH:11][CH:12]=[CH:13][C:8]=2[C:7](=[O:14])[N:6]([CH3:15])[C:5]2[CH:16]=[CH:17][C:18]([C:33]3[C:29]([CH3:28])=[N:30][NH:31][CH:32]=3)=[N:19][C:4]1=2)[CH3:2]Komponenten
3
Versuchsvorschrift
The title compound (mp 113°-115° C.) was prepared from 5,11-dihydro-11-ethyl-5-methyl-2-trifluoromethanesulfonyloxy-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one and 3-methyl-4-(tributylstannyl)pyrazole in a manner analogous to that described in Example 1.
Quellen und Nachweise
- ORD-Eintrag
- ord-9b48e23aca544f51aec4429709c28d9a
- Quelldatensatz
- uspto-grants-1998_11